Unedited LCD Supplement Ideas

Things you might think about "after" you have submitted an LCD request.

##

From Chat GPT 4.0, June 2023.

The MolDx review process, being government-operated, is indeed challenging to accelerate due to its complex nature. However, there are several strategies your company AAA might consider in an attempt to expedite the process and draw attention to the potential benefits of your ZZZ type test:

Peer-reviewed publications and case studies: There's nothing quite as powerful as sound scientific evidence to validate a novel diagnostic approach. Encourage the team to conduct more research using the test and publish in reputable journals. This evidence will be instrumental in the review process.

Engagement with Professional Organizations: Align with professional societies that have a vested interest in diagnostic testing or the patient populations your test may benefit. These groups can assist in lobbying and provide significant support. Their endorsement or recognition can add credibility and visibility.

Patient Advocacy Groups: Work with patient advocacy groups who can bring attention to the need for expedited review. The voices of patients, particularly those who are immunocompromised and may directly benefit from faster diagnosis, can be very powerful.

Public Awareness Campaigns: Implement a campaign to inform the public about your test's benefits and the roadblocks you face. Use both traditional and social media to share stories of how your testing has helped patients and physicians. Encourage doctors and patients to share their own stories. Create a hashtag for your campaign and try to generate viral attention.

Healthcare Provider Endorsements: Having physicians who understand the benefits of the AAA test could help advocate for its approval. They can write opinion pieces in medical journals, speak at conferences, and reach out directly to their networks.

Engage with Key Opinion Leaders (KOLs): Partnering with KOLs can significantly raise the profile of your test. They can support your cause by talking about your product in scientific meetings and conferences.

Collaboration with other diagnostic companies: Form alliances with other diagnostic companies facing similar challenges to lobby for more streamlined review processes. There's strength in numbers and shared experiences.

Direct Communication: Maintain frequent and open lines of communication with MolDx to ensure they have all the necessary information and understand the importance and urgency of your request.

Economic Value Proposition: Show how the AAA test might save Medicare money in the long run. Compare the cost of doing the test with the costs associated with delayed diagnosis and treatment in BBB patients.

Remember, while these strategies can help draw attention and potentially expedite the review process, it's critical to adhere to all the guidelines and requirements set forth by the MolDx program. Patience and persistence will be key.

##

What are pro's and con's of those tactics? One by one.

Sure, let's dive a bit deeper into each strategy, exploring their potential advantages and potential shortcomings:

1. Peer-reviewed publications and case studies

• Effective because:

• It provides robust scientific evidence for the effectiveness and reliability of the Karius test.
• It raises awareness within the medical community, which could lead to more support and endorsement.

• May be ineffective because:

• It takes a significant amount of time to conduct studies and get them published.
• Even once published, there's no guarantee that the right people at MolDx will see or be influenced by them.

2. Engagement with Professional Organizations

• Effective because:

• These organizations often have influential voices and extensive networks.
• They can lend credibility to your efforts and help lobby for a quicker review process.

• May be ineffective because:

• Some organizations might hesitate to get involved in lobbying for individual products.
• The process of getting the organizations on board can be time-consuming and doesn't guarantee success.

3. Patient Advocacy Groups

• Effective because:

• They can put a human face on the issue and generate public and political support.
• They are skilled in grassroots advocacy, which can garner significant attention.

• May be ineffective because:

• Some groups may have other priorities and may not choose to focus on your test.
• It might be challenging to mobilize patient groups quickly, which could delay the overall process.

4. Public Awareness Campaigns

• Effective because:

• It can raise broad public awareness and increase pressure on MolDx.
• Success stories from doctors and patients can be very persuasive.

• May be ineffective because:

• It can be costly and time-consuming to create and implement a successful campaign.
• There is a risk of backlash if the campaign is seen as pressuring a regulatory body.

5. Healthcare Provider Endorsements

• Effective because:

• Doctors are trusted figures, and their endorsements can be influential.
• They can share first-hand experiences of the benefits of your test, which can resonate with the MolDx team.

• May be ineffective because:

• Not all doctors may be willing to publicize their endorsement due to potential conflicts of interest.
• Physicians' opinions may not carry significant weight in a bureaucratic review process.

6. Engage with Key Opinion Leaders (KOLs)

• Effective because:

• KOLs have significant influence within the medical community and may sway the opinion of the MolDx team.
• They can speak about your product at scientific meetings and conferences, broadening its exposure.

• May be ineffective because:

• The KOL's audience may not include the decision-makers at MolDx.
• It might be challenging to get KOLs on board, especially if they perceive a conflict of interest.

7. Collaboration with other diagnostic companies

• Effective because:

• It creates a united front and amplifies the call for process efficiency.
• The shared experiences can provide a broader perspective on the problem and potential solutions.

• May be ineffective because:

• Other companies might see CLIENT as a competitor and be reluctant to collaborate.
• Different companies may have diverging priorities, making it hard to reach consensus on the best strategy.

8. Direct Communication

• Effective because:

• It ensures that MolDx has all the necessary information.
• It allows you to clarify any questions or concerns in real-time.

• May be ineffective because:

• MolDx might see this as overstepping boundaries or attempting to influence the process unduly.
• The MolDx staff may be too busy to maintain frequent communications.

9. Economic Value Proposition

• Effective because:

• It can appeal to MolDx's goal of cost-efficiency in healthcare.
• It presents the test as a long-term investment for better patient outcomes.

• May be ineffective because:

• The long-term cost savings may be difficult to quantify or prove convincingly.
• Economic arguments may not be compelling if MolDx prioritizes other factors like safety and efficacy.

Please note that these strategies should be used as a guide and may need to be adapted to the specific context and circumstances of your company and product.